Concepedia
Statistics
Publications
5
Citations
1.4K
H-Index
Active since
2012
Affiliations
University of Oxford(Current)
University of Cambridge
Oxford University Hospitals NHS Trust
Medway NHS Foundation Trust
Oxford University Clinical Research Unit
Sakkarai Ambalavanan is an author at University of Oxford specializing in pharmacotherapy, 28-day mortality, and internal medicine.
Publications per year
2012–2023
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
A Comparison of the Diagnostic Yield of Rigid and Semirigid Thoracoscopes
Asad Khan, Sakkarai Ambalavanan, David Thomson et al. · Journal of Bronchology & Interventional Pulmonology · 2012 · 47 citations
Medicine, Clinical Sciences, Surgery +10
1–5 of 5